Extracellular Vesicles as Markers and Mediators in Sepsis

Area of Science:

• Biomedical research
• Cell biology
• Critical care medicine

Background:

• Sepsis is a life-threatening condition with high mortality and inadequate diagnostic/therapeutic tools.
• Extracellular vesicles (EVs) are cell-released particles with potential as disease biomarkers.
• The role of EVs in sepsis is an emerging area of research.

Purpose of the Study:

• To review current research on EVs in septic patients.
• To discuss the diagnostic and therapeutic potential of EVs in sepsis.
• To highlight the need for standardization in EV research.

Main Methods:

• Literature review of studies on EVs in septic patients.
• Analysis of diagnostic and therapeutic applications of EVs.
• Discussion of EV roles in cell communication and sepsis pathogenesis.
• Examination of EV involvement in intensive care scenarios.

Main Results:

• Current studies on EVs in sepsis vary in quality and clinical utility.
• EVs have potential for early sepsis diagnosis and personalized treatment.
• EVs can mediate cell communication through microRNAs and involve microorganism-derived EVs.
• EVs may have both beneficial and detrimental roles in sepsis.

Conclusions:

• EVs offer bright prospects for sepsis management, including point-of-care diagnostics and individualized therapy.
• Standardization of methods and development of new analytical procedures are essential for advancing EV research in sepsis.
• Addressing technological gaps is critical for the clinical translation of EV-based sepsis strategies.